Navigation Links
Avastin, anti-Cancer Drug leads to Blindness and Other Complications

Researchers at the Genentech Inc.'s said that Avastin, a cancer drug may cause trigger a rare brain condition, reversible posterior leukoencephalopathy syndrome//. This was published in the New England Journal of Medicine.

It was found that two female cancer patients in their 50s treated with Avastin developed reversible posterior leukoencephalopathy syndrome (RPLS). This condition leads to blindness and other complications. Doctors said that both the patients have recovered.

Hal Barron, Genentech's chief medical officer said that his company is investigating a possible third case and is undertaking a review to see whether other patients have signs of the condition. The company also said that it will revise prescription information on the drug, which had $1.13 billion in sales last year.

Avastin is the first drug approved to fight cancer by choking off the blood supply that feeds the tumors. Parameswaran Hari, an assistant professor and oncologist at the Medical College of Wisconsin, in Milwaukee, who treated one of the patients, said that doctors should keep close watch for the syndrome in patients whose blood pressure rises during treatment with Avastin.

This results in the lesion formation in the brain which resembles a stroke leading to permanent vision loss and other complications if not treated immediately. This dangerous brain condition has been previously linked to treatment with chemotherapy and immune-suppressing drugs.


'"/>




Page: 1

Related medicine news :

1. Drinking arsenic water leads to cancer
2. Coronary stent leads to complications
3. Starving leads to obesity
4. Drug abuse leads to long standing changes in the brain
5. Deprived sleep leads to ageing
6. Tobacco chewing leads to dental caries
7. Tongue piercing leads to bacterial infection
8. Cathine leads to mental health disorder
9. Space research leads to needle-free blood tests
10. Canada stunned as mad cow discovery leads to beef ban
11. Doctor Pleads Not Guilty
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2016)... ... 04, 2016 , ... Are You Concerned About Mold In Your Home or ... Air Quality Companies in VA, MD and DC, recently completed its application for the ... mold law in the district of Columbia is a good thing stated John Taylor, ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... on the perils of heroin that was watched live by 1 million viewers ... I. duPont-Columbia University Award. , ASU students at the Walter Cronkite School of ...
(Date:12/2/2016)... CO (PRWEB) , ... December 02, 2016 , ... Advanced ... announced it has appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief ... for Advanced, Inc. , Jason brings extensive financial and operational leadership experience to ...
(Date:12/2/2016)... , ... December 02, 2016 , ... U.S. Surgeon General, ... with Mediaplanet, Dr. Murthy explains how he was inspired to practice medicine at an ... that medicine is about more than making diagnoses and prescribing medicine,” he states. “It ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... More than ... and while 84 percent of parents report speaking with their child about sex related ... sexually transmitted diseases. , Mediaplanet is proud to announce the launch of its second ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... WOONSOCKET, R.I. , Dec. 2, 2016 ... hold its annual Analyst Day in New York City on Thursday, December ... the CVS Health leadership team will provide an in-depth ... and enhance shareholder value. The company will also discuss ... audio and video webcast of the event will be ...
(Date:12/2/2016)... -- Orthopedic Implants (Including Spinal Implants, Reconstructive Joint ... a Significant Market Share Owing to a Large Global Baby ... ... According to a new report by Persistence Market Research ... Product Type Segment Projected to Witness a Significantly High CAGR ...
(Date:12/2/2016)... 2, 2016   CytoSorbents Corporation (NASDAQ: ... European Union approved CytoSorb ® cytokine adsorber to ... worldwide, announced that Dr. Phillip Chan , Chief ... LD Micro Main Event investor conference held from ... Luxe Sunset Boulevard Hotel in Los Angeles, ...
Breaking Medicine Technology: